Found: 14
Select item for more details and to access through your institution.
New agents in cancer clinical trials.
- Published in:
- Oncogene, 2000, v. 19, n. 56, p. 6687, doi. 10.1038/sj.onc.1204088
- By:
- Publication type:
- Article
The influence of corticosteroids on the release of novel biomarkers in human endotoxemia.
- Published in:
- Intensive Care Medicine, 2008, v. 34, n. 3, p. 518, doi. 10.1007/s00134-007-0955-x
- By:
- Publication type:
- Article
Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo.
- Published in:
- BMC Systems Biology, 2009, v. 3, p. 1, doi. 10.1186/1752-0509-3-31
- By:
- Publication type:
- Article
The Proteasome Inhibitor Bortezomib (Velcade) Sensitizes Some Human Tumor Cells to Apo2L/TRAIL-Mediated Apoptosis.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1059, n. 1, p. 160, doi. 10.1196/annals.1339.042
- By:
- Publication type:
- Article
The Handmaid's Myth.
- Published in:
- 2019
- By:
- Publication type:
- Television Review
AMPK regulates energy expenditure by modulating NAD<sup>+</sup> metabolism and SIRT1 activity.
- Published in:
- 2009
- By:
- Publication type:
- Letter
26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer.
- Published in:
- Journal of Cellular Biochemistry, 2001, v. 82, n. 1, p. 110, doi. 10.1002/jcb.1150
- By:
- Publication type:
- Article
Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
- Published in:
- Cardiovascular Research, 2011, v. 89, n. 2, p. 464, doi. 10.1093/cvr/cvq339
- By:
- Publication type:
- Article
Proteasome inhibition: a new anti-inflammatory strategy.
- Published in:
- Journal of Molecular Medicine, 2003, v. 81, n. 4, p. 235, doi. 10.1007/s00109-003-0422-2
- By:
- Publication type:
- Article
Sirtuins — novel therapeutic targets to treat age-associated diseases.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice
Sirtuins — novel therapeutic targets to treat age-associated diseases.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 10, p. 841, doi. 10.1038/nrd2665
- By:
- Publication type:
- Article
Delayed Treatment With MLN519 Reduces Infarction and Associated Neurologic Deficit Caused by Focal Ischemic Brain Injury in Rats via Antiinflammatory Mechanisms Involving Nuclear Factor-κB Activation, Gliosis, and Leukocyte Infiltration.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2003, v. 23, n. 1, p. 75, doi. 10.1097/01.WCB.0000039285.37737.C2
- By:
- Publication type:
- Article
Quantitative Real-Time RT-PCR Analysis of Inflammatory Gene Expression Associated With Ischemia-Reperfusion Brain Injury.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2002, v. 22, n. 9, p. 1068, doi. 10.1097/00004647-200209000-00004
- By:
- Publication type:
- Article
Postischemic Administration of AK275, a Calpain Inhibitor, Provides Substantial Protection Against Focal Ischemic Brain Damage.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 1994, v. 14, n. 4, p. 537, doi. 10.1038/jcbfm.1994.67
- By:
- Publication type:
- Article